Skip to content

Clinical trials

Observational Pancreatic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Observational Country / region: United States Clear all

229 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20024
20031
20049
20054
20068
20079
200812
20097
20106
20116
20124
201314
20148
201511
201613
201714
201814
201910
20209
202114
202214
202310
20248
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Recruiting57
Terminated22
Active, not recruiting17
Unknown status16
Withdrawn10
Not yet recruiting5
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic12
Memorial Sloan Kettering Cancer Center12
M.D. Anderson Cancer Center8
Columbia University7
H. Lee Moffitt Cancer Center and Research Institute7
National Cancer Institute (NCI)7
Johns Hopkins University6
Stanford University5
Wake Forest University Health Sciences5
Case Comprehensive Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms229
Colorectal Neoplasms36
Stomach Neoplasms36
Lung Neoplasms33
Breast Neoplasms31
Esophageal Neoplasms28
Ovarian Neoplasms27
Liver Neoplasms26
Colonic Neoplasms25
Neoplasms23

Trials

Showing 1 to 25 of 229. Each trial links to its page on Pharma Observatory.

129 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.